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BACKGROUND:  Moulds  are  present  in  a  variety  of
environments  and  aerosols  of  fungal  spores  are
generated when mouldy materials are handled. Molds
contain  (1® 3)-b -D-glucan,  a  polyglucose  which  is
present in the cell wall of fungi, certain bacteria and
plants.
Aim:  This  study  was  undertaken  to  investigate  the
cellular  inflammatory  response  in  the  lung  after
inhalation  of  (1® 3)-b -D-glucan  and  bacterial
endotoxin.
Methods:  Guinea  pigs  were  exposed  daily  to  an
aerosol  of  pure  (1® 3)-b -D-glucan  and  pure  endo-
toxin for five weeks. Lung lavage and lung interstitial
cell  preparations  were  done and  the  inflammatory
cells  counted.  Histological  sections  were  prepared
from the trachea.
Results:  There  was  an increase  in  eosinophil num-
bers in lung lavage, lung interstitium, and the airway
epithelium of animals exposed to (1® 3)-b -D-glucan.
In  animals  simultaneously  exposed  to  endotoxin,
there  was  no  increase  in  eosinophils.  In  the  lung
interstitium,  (1® 3)-b -D-glucan  exposure  caused  an
increase in lymphocytes, which was not found after
endotoxin exposure. Endotoxin exposure caused an
increase  in  neutrophils  and  macrophages  in  lung
lavage, which was not found after (1® 3)-b -D-glucan
exposure.
Conclusions:  The  results  support  previous  findings
that (1® 3)-b -D-glucan causes a different response in
the  airways  as  compared  to  endotoxin.  Endotoxin
modulated  the  increase  in  eosinophils  caused  by
(1® 3)-b -D-glucan  exposure,  suggesting  a  complex
interaction  between  the  microbial  cell  wall
components.
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Introduction
Moulds  are  present  in  occupational  and  general
environments. Aerosols of fungal spores are generated
when mouldy  materials are handled. High amounts
have  been  reported  in  farm  environments  where
mouldy hay is handled, in areas where mouldy wood
is  processed  and  inside  humid  buildings.1 Moulds
contain a number  of  bioactive substances that may
produce toxic effects and interact with the immune
system.2 Of particular interest is (1® 3)-b -D-glucan, a
polyglucose  compound  present  in  the  cell  wall  of
fungi, certain bacteria and plants including pollen.3
The effects of (1® 3)-b -D-glucan on inflammatory and
immune competent cells in general have been docu-
mented  in  several  in  vitro and  in  vivo animal
models.4–9
In comparison with the abundance of information
on the effects of (1® 3)-b -D-glucan administered by
injection using in vivo models, data on the effects of
inhalation  are  limited.  Previous  reports  from  our
laboratory have demonstrated that an acute inhalation
of  (1® 3)-b -D-glucan  in  guinea  pigs  prevented  an
endotoxin  induced  invasion  of  neutrophils  in  the
airways.10 Another study involved a five-week expo-
sure,  which  caused  an  increase  in  the  number  of
neutrophils  in  the  airways  when  endotoxin  was
administered  alone,  but  no  such  effect  was  found
after exposure to (1® 3)-b -D-glucan alone.11 An even
greater increase in neutrophil numbers was observed
when  endotoxin  was  administered  together  with
(1® 3)-b -D-glucan.  These  data  suggest  that  inhaled
(1® 3)-b -D-glucan initiates a response that is different
from that induced by inhaled endotoxin as there is no
increase in the number of neutrophils – the hallmark
of endotoxin exposure.
There is  also  information  on other inflammatory
cells.  In  a  subchronic  study  using  guinea  pigs,  an
infiltration  of  eosinophils  was  seen  in  the  trachea
epithelium of animals exposed to (1® 3)-b -D-glucan.12
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min, it was found that (1® 3)-b -D-glucan potentiated
the ovalbumin-induced eosinophilia in the airways.13
The  present  experiments  were  undertaken  to
further  study  the  ability  of  (1® 3)-b -D-glucan  to
induce an inflammatory response in the lungs after a
subchronic  inhalation  exposure  and  to  study  the
effect of a simultaneous exposure to endotoxin.
Material and methods
Animals
Male and female guinea pigs from our own breeding
colony with an initial weight of about 700g were used
in  the experiments. All  animals were kept in cages
supplied  with  filtered  air  at  a  slight  overpressure.
Food and water were supplied ad lib. Each exposure
group had the same proportion of females and males.
The animals were without signs of latent infections in
the  airways,  as  evaluated  by  a  low  number  of
inflammatory cells in the lavage fluid of unexposed
animals.
(1® 3)-b -D-glucan exposure
For the (1® 3)-b -D-glucan exposures, we used grifo-
lan, prepared from the mushroom Grifolanum com-
mune, which is non-soluble in water (kindly supplied
by Professor N. Ohno, Tokyo). It was rendered water-
soluble by suspending it in 0.3N NaOH and was then
diluted with distilled water into 10 m g/ml. An aerosol
was generated using  a Collison atomizer,14 and the
animals were exposed in a small exposure chamber in
a continuous flow system. The animals were exposed
for  four  hours  a  day,  five  days  a  week,  for  five
weeks.
The amount of (1® 3)-b -D-glucan in the chamber
air was 30 m g/m3, yielding an estimated dose of about
1.5ng/animal/day, presuming a 50% deposition of the
inhaled small-particulate aerosol and using previously
published data on ventilation in guinea pigs.15
Endotoxin exposure
For the endotoxin exposure, we used a solution in
water  containing  25 m g/ml  of  lipopolysaccharide
(LPS, Escherichia coli 026 B6,  Difco lab) in similar
exposure equipment. The animals were exposed for
40min a day prior to the (1® 3)-b -D-glucan exposure,
five days/week for five weeks. The amount of LPS in
the chamber was 75 m g/m3, yielding a dose of about
4ng/animal and day.
Examination
At 24 hours after the last exposure, the animals were
anaesthetized with an i.p. injection of sodium pento-
barbital (120mg/ml). The thoracic cavity was opened
and  the  lung  vascular  bed  perfused  with  chilled
Dulbecco’s PBS (phosphate-buffered saline) without
Mg2+ and Ca2+ (DPBS, NordCell, Sweden). Perfusion
was performed until the lungs  were clear white, at
which point the aorta was tied off. The right lung was
used  for  determining  the  number  of  inflammatory
cells in the lavage fluid and in the lung interstitium.
The trachea was used for histological examinations.
Lung lavage cells (LLC)
The right lung was subjected to lung lavage in situ
after  forceps  had closed the left  main  bronchus. A
portion of 70ml saline was used at a body weight of
700–800g;  for  each  additional  100g,  the  lavage
volume  was  increased  by  10ml.  The  saline  was
divided into 10 aliquots, which were slowly injected
into the lung lobes via a cannula in the trachea. After
each instillation,  the  fluid  was  withdrawn  and  col-
lected in 50-ml  centrifuge tubes placed on ice. The
lavage fluid was centrifuged at 350´ g for 10min, and
the cell pellet was collected, resuspended and coun-
ted in a light microscope. A cell differentiation was
done  using  May–Gr¨ unewald–Giemsa  stain.  These
cells are referred to as lung lavage cells (LLC).
Lung interstitial cells (LIC)
After  the  lung  lavage,  the  right  lung  was prepared
according to a method previously described.11,16 The
trachea was cut off beneath the larynx, and the whole
lung was removed from the thoracic cavity. The upper
right lobe was placed on a filter paper and sliced into
0.4mm thick sections. About 0.8g of lung tissue was
suspended in  siliconized flasks containing 10ml  of
PBS with 10% inactivated calf serum, 175 units/ml of
collagenase (Boehringe, Mannheim, Germany) and 50
units/ml  of  DNAse  (Sigma,  St  Louis  MO,  USA).
Following an incubation of 90min in a shaking water
bath (180s.p.m. 37° C), the preparation was agitated
and remaining tissue fragments in the cell slurry were
removed  by  filtration  through  a  thin  cotton  wool
plug.  The  cells  were  collected  by  centrifugation,
counted  and  typed.  Cell  viability  was  checked  by
Trypan  blue  exclusion  (the  viability  range  was
80–92%). These cells are referred to as lung interstitial
cells (LIC).
Eosinophils in the tracheal epithelium
The trachea was fixed in 4% buffered formaldehyde
and was sectioned longitudinally, including  the first
bifurcation, and stained with Weigert haematoxylin-
eosin. The  degree  of  eosinophil  infiltration  in  the
epithelial layer was calculated at three different levels
in  the  trachea.  One  level  was  right  below  the
bifurcation (level A), another near the fifth gristle ring
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above the bifurcation (level C).
Statistics
The mean and median numbers of each cell type in
the LLC and LIC preparations were calculated for each
group of animals. In the same manner, the mean and
median numbers of eosinophils at each level in the
trachea epithelium were calculated for each group of
animals. The  differences  between  the  groups  were
evaluated  using  two-sided  Mann–Whitney  U-test.
Differences were considered statistically significant at
p<0.05.
Results
The  animals  tolerated  the  exposures  well  and  no
effect on weight development was found. There were
no respiratory distress symptoms  i.e.  there was no
indication of sensitization to either of the agents used.
The numbers of different cells in the lung lavage and
lung interstitium are shown in Figs 1–4.
In the controls, the macrophage was the dominant
cell  type  both  in  the  lung  lavage  and  the  lung
interstitium.  The  proportions  of  cells  in  the  two
compartments varied; macrophages were about three
times  more  numerous  per  gram  lung  in  the  inter-
stitium than in the lung lavage. For the neutrophil and
(1® 3)-b -D-glucan and airway eosinophilia
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FIG. 1. The numbers of  macrophages in lung lavage fluid (black bars) and lung interstitium (grey bars). The results are
presented as mean values with standard deviations. *p<0.05, **p<0.01, ***p<0.001 as compared to controls.
FIG. 2. The numbers of lymphocytes in lung lavage fluid (black bars) and lung interstitium (grey bars). The results are presented
as mean values with standard deviations. *p<0.05, **p<0.01, ***p<0.001 as compared to controls.lymphocyte  numbers,  the  differences  were  even
larger with the numbers in the interstitium, almost
hundred-fold  higher  for  neutrophils  and  20-fold
higher for  lymphocytes as compared with the lung
lavage. For eosinophil numbers there was only a small
difference.
The numbers of macrophages in lung lavage fluid
and  lung  interstitium  are  shown  in  Fig.  1.  After
endotoxin  exposure,  the  numbers  of  macrophages
were increased in the lung  lavage as well as in the
lung  interstitium. A  similar  result  was  found  when
(1® 3)-b -D-glucan  was  inhaled  together  with  endo-
toxin.  No effect  was  found  after  (1® 3)-b -D-glucan
exposure  alone.  The  numbers  of  lymphocytes  in
lung lavage fluid and lung interstitium are shown in
Fig. 2.
After endotoxin exposure, the number of lympho-
cytes was moderately increased in lung lavage but no
increase  was  found  in  the  lung  interstitium.
(1® 3)-b -D-glucan  exposure  caused  an  increase  in
lymphocyte numbers, both in lung  lavage and lung
interstitium.  In  animals  simultaneously  exposed  to
endotoxin, the (1® 3)-b -D-glucan-induced increase in
lymphocyte numbers was not present. The numbers
of  neutrophils  in  lung  lavage  fluid  and  lung  inter-
stitium are shown in Fig. 3.
After  exposure  to  endotoxin,  the  number  of
neutrophils was increased in lung lavage but not in
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FIG. 3. The numbers of neutrophils in lung lavage fluid (black bars) and lung interstitium (grey bars). The results are presented
as mean values with standard deviations. ***p<0.001 as compared to controls.
FIG. 4. The numbers of eosinophils in lung lavage fluid (black bars) and lung interstitium (grey bars). The results are presented
as mean values with standard deviations. *p<0.05, ***p<0.001 as compared to controls.lung  interstitium.  No  effect  was  found  after
(1® 3)-b -D-glucan exposure. When (1® 3)-b -D-glucan
was inhaled together with endotoxin, the result was
similar as compared with endotoxin exposure alone.
The numbers of eosinophils in lung lavage fluid and
lung interstitium are shown in Fig. 4.
After endotoxin exposure, the numbers of eosino-
phils was slightly increased in lung lavage and lung
interstitium, but the differences were not statistically
significant.  After  (1® 3)-b -D-glucan  exposure,  the
numbers of eosinophils were significantly  increased
both in the lung lavage and in the lung interstitium as
compared with controls. Simultaneously exposure to
endotoxin  decreased  the  (1® 3)-b -D-glucan-induced
increase in both sites. The number of eosinophils in
the tracheal epithelium is shown in Table 1. In animals
exposed  to  endotoxin,  there  was  a  tendency  to
a  lower  number,  which  was  significant  at  level  C
as  compared  with  controls.  Exposure  to
(1® 3)-b -D-glucan caused an increase in the eosino-
phil numbers. In animals simultaneously exposed to
endotoxin, the (1® 3)-b -D-glucan-induced increase in
eosinophil  numbers  was  not  present,  instead  a
significantly lower number of eosinophils was present
as compared with controls.
Discussion
The animals were exposed by inhalation to doses of
endotoxin and (1® 3)-b -D-glucan that were similar to
amounts found in the environment. On the cellular
level, the doses were far inferior to those used in in
vitro experiments. A  calculation  of  the  amount  of
(1® 3)-b -D-glucan in relation to the number of macro-
phages  in  the  lung17 showed  that the  dose  at  the
cellular  level  in  this  experiment  corresponded  to
about 0.15ng/106 macrophages. In in vitro studies,
the doses used are often in the order of 0.5 to 10 m g
for the  same  number  of  macrophages. Against  that
background, one should be careful when extrapolat-
ing reactions in in vitro studies to effects found in
vivo after inhalation.
The  major  finding  in  the  study  was  that  the
exposure to (1® 3)-b -D-glucan caused an increase in
the number of eosinophils in the airway epithelium.
This  is  consistent  with  a  previous  report  where
another  kind  of  (1® 3)-b -D-glucan  (curdlan)  was
used.12 In another study that used a similar exposure
protocol, a large increase in eosinophil numbers was
seen after exposure to ovalbumin, but no effect was
found  after  (1® 3)-b -D-glucan  exposure.18 The  dis-
crepancy  between  these  studies  could  be  a  con-
sequence of having examined the animals in the last
study 48 hours after the last exposure as compared to
24 hours after exposure in the previous studies.
The  increase  in  eosinophil  numbers  found  after
(1® 3)-b -D-glucan  exposure  was  decreased  by  a
simultaneous  exposure  to  endotoxin. This  effect  is
consistent with findings in a previous study, where
an  ovalbumin-induced  eosinophilia  in  lung  lavage
was decreased by a simultaneous exposure to endo-
toxin.18 It is conceivable that the macrophage stim-
ulation  brought  about  by  endotoxin  induced  the
secretion of cytokines, e.g. tumour necrosis factor a
(TNFa )19,20 and interleukin (IL)–12 (Th1 promoting
pattern),  that  depressed  the  release  of  cytokines
involved in eosinophil effects such as IL–5 and IL–
10 (Th2 promoting pattern). Unfortunately no meas-
urements of such cytokines could be undertaken in
this  study  due  to  the  lack  of  suitable  reagents  in
guinea pigs. Guinea pigs normally have a rather high
amount  of  eosinophils,  but  this  could  not  explain
the  different  responses  found  after  endotoxin  and
(1® 3)-b -D-glucan  exposures  as  they  are  compared
to the same controls.
The  results  in  the  present  study  suggest  that
endotoxin  and  (1® 3)-b -D-glucan  activate  different
inflammatory mechanisms when inhaled. The endo-
toxin exposure caused an increase in the numbers of
(1® 3)-b -D-glucan and airway eosinophilia
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Table 1. Eosinophilic leukocytes in tracheal epithelium (cells/field at 40´ magnification) of guinea pigs exposed to endotoxin,
(1® 3)-b -D-glucan (GLU) or endotoxin + GLU
Exposure m g/ml Levels in the trachea
A B C
Controls – 15.1 (6.6) 32.0 (10.8) 35.6 (12.4)
Median 17.5 33.0 36.0
Endotoxin 25 13.0 (8.2) 24.0 (14.5) 22.6 (12.7)*
Median 12.5 24.50 23.25
GLU 10 41.1 (22.4)** 53.4 (30.6)* 57.0 (39.4)
Median 39.75 47.50 55.25
GLU+Endotoxin 10 + 25 6.9 (6.9)** 9.5 (7.4)*** 7.6 (6.3)***
Median 4.00 7.75 6.75
Means, medians and standard deviations in parentheses. A = a level right below the bifurcation, B = a level near the fifth gristle ring, C = a level
near the seventh gristle ring above the bifurcation. Controls n = 13, endotoxin n = 10 and GLU n = 10.
*p<0.05, **p<0.01, ***p<0.001 as compared to controls.neutrophils and macrophages without an increase in
eosinophil numbers and lung interstitial lymphocytes,
while  the  (1® 3)-b -D-glucan  exposure  caused  an
increase in eosinophil numbers and lung interstitial
lymphocytes, without an increase in neutrophil and
macrophage numbers. There are previous studies that
further support that (1® 3)-b -D-glucan acts through a
different mechanism as compared with endotoxin. In
a mouse model, there was an increase in the secretion
of  IL–10  and  a  decreased secretion  of  IL–12  after
(1® 3)-b -D-glucan exposure.13 A depression of inflam-
matory cytokines, including TNFa , in mice pretreated
with  soluble  (1® 3)-b -D-glucan  has  recently  been
reported.21 In a recent acute inhalation experiment in
humans, the subjects inhaled (1® 3)-b -D-glucan and
saline in a random, double-blind design (manuscript
submitted  for  publication).  Inhalation  of
(1® 3)-b -D-glucan  decreased  the  phytohaemaggluti-
nin  (PHA)  induced  TNFa production  from  blood
mononuclear  cells.  The  number  of  eosinophils  in
blood was significantly decreased 72h after exposure,
suggesting a recruitment of eosinophils into the lung
tissue. No increase in the number of neutrophils was
found.  These  results  indicate  that  exposure  to
(1® 3)-b -D-glucan could induce a Th2 type cytokine
secretion pattern.
In  a  previous  experiment  involving  acute  expos-
ures,  (1® 3)-b -D-glucan  was  found  to  block  the
endotoxin-induced neutrophil recruitment in a dose
dependent fashion. While this blocking effect could
be  explained  by  a  down-regulation  of  macrophage
activity, caused by the secretion of interleukin recep-
tor  antagonists  induced  by  (1® 3)-b -D-glucan,22 no
such  effect  could  be  demonstrated  in  the  present
experiment  involving  a  subchronic  exposure. This
suggests  that  the  blocking  effect  is  a  temporary
phenomenon  and  that  macrophages  regain  their
capacity  to  secrete  neutrophil  attracting  cytokines
such as TNFa and IL–1 after repeated exposures.
Another  study  involving  subchronic  exposures,11
suggested a synergistic effect between endotoxin and
(1® 3)-b -D-glucan with respect to neutrophil recruit-
ment into the airways but no such effect was found in
the present study. The reason for the discrepancy may
be due to the different structures/preparations of the
two types of (1® 3)-b -D-glucan used in the different
experiments.  The  experiment  where  a  synergistic
effect  was  suggested  used  the  (1® 3)-b -D-glucan
curdlan. This  has  a  single  helix  structure  and  was
administered  in  a  saline  suspension.  The  present
experiment  used  grifolan  which  has  a  triple  helix
structure and was suspended in 0.3N NaOH to render
it water-soluble. Regarding the recruitment of eosino-
phils,  however,  the  two  types  of  (1® 3)-b -D-glucan
caused similar responses. In this study grifolan caused
an increase in eosinophils in the airway epithelium,
which  is  consistent  with  the  results  of  a  previous
study where curdlan was used.12
In  conclusion,  the  results  provide  further  evi-
dence  that  (1® 3)-b -D-glucan  induces  a  different
response  in  lung  inflammatory  cells  than  occurs
after  exposure  to  endotoxin. They  further  suggest
that (1® 3)-b -D-glucan can cause an eosinophil domi-
nated  inflammatory  response  in  the  airway  epithe-
lium  which  is  abrogated  by  a  simultaneous  endo-
toxin  exposure,  suggesting  a  complex  interaction
between  these  environmental  microbial  cell  wall
components. Finally, the results illustrate the need to
evaluate  different  compartments  of  the  lung  –  air-
way  spaces,  epithelium  and  lung  interstitium  –  in
order to understand the complicated cell  dynamics
that constitute the response to inhaled microbial cell
wall agents.
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